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Abstract: This study aims to evaluate the natural history, disease progression, and outcomes in
dichorionic twins with selective fetal growth restriction (sFGR) according to different diagnostic
criteria and time of onset. Dichorionic twins seen from the first trimester were included. sFGR was
classified according to the Delphi consensus, and was compared to the outcomes of those classified
by the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) diagnostic criteria.
Early sFGR occurred before 32-weeks, and late sFGR after 32-weeks. Disease progression, neonatal
outcomes such as gestation at delivery, birthweight, neonatal unit (NNU) admission, and morbidities
were compared. One-hundred twenty-three of 1053 dichorionic twins had sFGR, where 8.4% were
classified as early sFGR, and 3.3% were late sFGR. Disease progression was seen in 36%, with a
longer progression time (5 vs. 1 week) and higher progression rate (40% vs. 26%) in early sFGR.
Perinatal death was significantly higher in the sFGR than the non-sFGR group (24 vs. 16 per 1000
births, p = 0.018), and those with early sFGR had more NNU admissions than late sFGR (p = 0.005).
The ISUOG diagnostic criteria yielded a higher number of sFGR than the Delphi criteria, but similar
outcomes. sFGR have worse perinatal outcomes, with early onset being more prevalent. Use of the
Delphi diagnostic criteria can reduce over-diagnosis of sFGR and avoid unnecessary intervention.
Keywords: DCDA twins; selective fetal growth restriction; morbidity and mortality; natural history;
diagnostic criteria
1. Introduction
Twin pregnancies carry a higher risk of prenatal complications, such as selective fetal growth
restriction (sFGR), preterm birth, perinatal morbidity, and mortality [1]. sFGR is seen less commonly
in dichorionic (DC) than monochorionic (MC) twin pregnancies, with a reported prevalence of 10.5%
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compared to 19.7%, respectively [2]. DC twin pregnancies are believed to have a lower perinatal
mortality rate than MC twins (33 per 1000 vs. 75 per 1000) [3], as well as a lower rate of neurological
co-morbidities [4]. The recommended management for sFGR in DC twin pregnancies is the same as
that of growth restricted singletons [1,5]. However, the evidence available to support this is scarce [6],
and most of the literature on this subject largely focuses on MC twins.
sFGR in MC twins is thought to be caused by an unequal sharing of the placenta and distribution
of blood through placental anastomoses [7], whereas in DC twins, from placental insufficiency in
one of the placentas [4]–explaining the higher incidence of pre-eclampsia in DC than MC twins with
sFGR [8]. Other causes can include congenital infections, or discordant anomalies, which can be
excluded through detailed ultrasound assessment, maternal serology and invasive prenatal testing [5].
Recent evidence has suggested that the natural history of sFGR in DC twins may not be so similar to
that of singletons. Vanlieferinghen et al have found that the interval from development of umbilical
artery Doppler abnormalities to birth was significantly longer in growth restricted DC twins than in
growth restricted singletons [9].
The classification of sFGR has shown significant variation, making evaluations and comparisons
of prevalence and outcomes of this pathology difficult. The International Society of Ultrasound in
Obstetrics and Gynecology (ISUOG) defines sFGR in DC twins as an estimated fetal weight (EFW)
<10th centile [5,10]. A recent consensus, using the Delphi procedure, has focused on achieving uniform
diagnostic criteria and reporting parameters in twin pregnancies with sFGR. This classified sFGR
in DC twins as either the EFW of one twin <3rd centile, or when two of the following parameters
were met-EFW of one twin <10th centile, EFW discordance >25%, or umbilical artery pulsatility index
(UA PI) >95th centile of the smaller twin [10]. The main aim of this study is to assess the natural
history and perinatal outcomes of sFGR in DC twin pregnancies, according to the time of onset and the
different reported diagnostic criteria.
2. Experimental Section
This was a longitudinal cohort study of all dichorionic diamniotic (DCDA) twin pregnancies
that had their routine antenatal care at the Fetal Medicine Unit at St. George’s Hospital, University
of London. The pregnancies were identified retrospectively by searching the ultrasound database
(ViewPoint version 5.6.26.148, ViewPoint Bildverarbeitung GMBH, Wessling, Germany). All DCDA
twin pregnancies with confirmed chorionicity at 11–14 weeks of gestation, who underwent routine
scans at our Fetal Medicine Unit from January 2000 until January 2019 were included in the study.
Dichorionicity was diagnosed using the presence of the lambda-sign in the inter-twin membrane at the
site of membrane insertion into the placenta, during the first trimester ultrasound scan between 11 and
14 weeks. Gestational age (GA) was determined according to the crown rump length (CRL) of the
larger twin in spontaneous pregnancies, and according to the date of oocyte retrieval or embryonic
age from fertilization in cases of pregnancies conceived via in vitro fertilization (IVF). The patients
had four weekly scans following the anomaly scan, and 1–2 weekly scans after the diagnosis of sFGR,
or more frequently if clinically indicated as per the fetal umbilical artery Doppler findings.
Pregnancies diagnosed with sFGR underwent testing modalities in the form of a detailed anomaly
scan, Doppler (umbilical artery, middle cerebral artery, and ductus venosus) assessment, TORCH
screen, and karyotyping if they wished to exclude genetic syndromes and aneuploidies. Pregnancies
complicated by major fetal structural anomalies, aneuploidy, genetic syndromes or lost to follow-up
were excluded from the analysis. We also excluded the pregnancies where both fetuses were growth
restricted. The pregnancy outcomes were obtained from the maternity database and the neonatal
records. Those with positive TORCH results were counseled and managed accordingly. The pregnancies
were managed according to the following protocol: expectant management prior to 30 weeks’ gestation;
elective birth if abnormal ductus venosus (DV) Doppler at or beyond 30 weeks after a course of steroids;
elective birth if reversed end-diastolic flow (EDF) in the umbilical artery (UA) at or beyond 31–32 weeks
after a course of steroids, elective birth if absent EDF in the UA at or beyond 32–33 weeks after a
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course of steroids; elective birth if the UA pulsatility index (PI) is at or above the 95th centile (even
with positive EDF) at or beyond 34 weeks after a course of steroids; elective birth if middle cerebral
artery (MCA) PI <5th centile at or beyond 36 weeks; and deliver all those with normal fetal Dopplers at
or beyond 37 weeks. Pregnant women who underwent planned delivery before 34 weeks’ gestation
underwent a Caesarean section, as did those who had maternal reasons for Caesarean section who
delivered after 34 weeks.
The inter-twin discordance was calculated as the EFW difference divided by the EFW of the larger
twin multiplied by 100. The EFW prior to 20 weeks was derived by the formula by Warsof et al., and at
20 weeks or beyond it was derived by the formula of Hadlock et al [11,12]. Growth was evaluated using
the STORK twin growth charts [13]. Birthweight percentiles were calculated using twin chorionicity
specific reference standards reported by Ananth et al [14]. Based on the recently published consensus
on the diagnostic criteria for sFGR in twin pregnancies [10], one solitary parameter irrespective of
chorionicity (EFW of one twin < 3rd centile), or two of the three contributory criteria (EFW of one
twin < 10th centile, EFW discordance ≥ 25%, or UA PI of the smaller twin > 95th centile) were used
to diagnose sFGR. A pregnancy was considered to be affected by sFGR if it fulfilled the criteria in
two or more scans in order to avoid over-diagnosis taking into account the limitations of ultrasound
assessment of the EFW in twin pregnancies.
In line with a recent Delphi consensus on fetal growth restriction (FGR) in singleton pregnancies [15],
we defined early sFGR as sFGR occurring before 32 weeks and late sFGR as after 32 weeks’ gestation.
This difference in classification from MC twins (early sFGR before 24 weeks and late sFGR after
24 weeks) was due to the fact that DC twins with sFGR would unlikely undergo the same interventions
as MC twins (e.g., fetoscopic laser or bipolar cord occlusion), and are often managed similarly to
singleton pregnancies. Doppler assessment of the UA of both twins and the classification of EDF as
normal, absent, or reversed was carried out in all cases, at each ultrasound assessment. Miscarriage
was defined as the death of at least one twin up to 20 weeks’ gestation and intrauterine demise (IUD)
after 20 weeks. Neonatal death (NND) was defined as the death of at least one newborn up to 28 days
of life. Perinatal death (PND) was defined as the sum of IUD and NND.
To assess disease progression of the sFGR twin, we calculated the time interval between the
gestational age at the first ultrasound scan at diagnosis, and the scan displaying the following worsening
fetal parameters: increase in the UA PI from normal to above the 95th centile, or EDF changes from
positive to absent, or from absent to reversed EDF, or the presence of an absent or reversed a-wave in
the ductus venosus.
Statistical Analysis
Continuous variables were presented as either median and interquartile range or mean and
standard deviation according to distribution characteristics. Normality assumptions were tested with
Shapiro-Wilk test. Continuous variables were compared using either t-test or Wilcoxon rank-sum test
depending on the distribution characteristics. Categorical variables were compared using chi-squared
test or Fisher’s exact test where appropriate. For comparison using fetus level data, generalized
estimating equations were used to account for inter-twin dependency structure. p values below 0.05
were considered statistically significant. All statistical analyses were performed using R for statistical




Our study cohort included 1249 DC twin pregnancies. Figure 1 shows a flowchart of the initially
1249 screened DCDA twin pregnancies and the reasons for the exclusion of 196 DCDA twin pregnancies
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from further analysis. Twenty-eight pregnancies were excluded due to fetal anomalies, 12 pregnancies
had FGR in both babies, 4 pregnancies were terminated, 48 pregnancies miscarried, and 104 were lost
to follow-up. A total of 1053 DC twin pregnancies were included in our final analysis. There were
no significant differences in maternal age (p = 0.409), body mass index (BMI) (p = 0.231), or mode of
conception (p = 0.333) between sFGR and normal groups (Table 1). There were more women of Asian
origin (21.1% vs. 12.2%, p = 0.032) and less women of Afro-Caribbean origin (8.9% vs. 14.1%, p = 0.032)
in the sFGR group than the group without sFGR.
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Figure 1. Flow diagram representing the whole study population of dichorionic diamniotic twin 
pregnancies (n = 1249). DCDA: dichorionic diamniotic, sFGR: selective fetal growth restriction. * 
Incidence of sFGR classified according to Delphi diagnostic criteria. 
Figure 1. Flow diagram representing the whole study population of dichorionic diamniotic twin
pregnanci s (n = 1249). DCDA: dichorionic diamniotic, sFGR: selective fetal growth restriction.
* Incidence of sFGR classified according to Delphi diagnostic criteria.
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Table 1. Baseline characteristics of the dichorionic diamniotic (DCDA) twin pregnancies, according to




(n = 930) p-Value
Maternal age in years (mean ± SD) 34.0 (29.0–36.0) 34.0 (30.0–36.0) 0.409
Maternal body mass index in Kg/m2
(mean ± SD)
24.0 (21.0–27.0) 24.0 (22.0–27.4) 0.231
Mode of conception
Spontaneous conception, n (%) 83 (67.5) 586 (63.0)
0.333
IVF, n (%) 40 (32.5) 344 (37.0)
Ethnicity, n (%)
White 79 (64.2) 639 (68.7)
0.032Black 11 (8.9) 131 (14.1)
Asian 26 (21.1) 113 (12.2)
Other 7 (5.7) 47 (5.1)
* Classified according to the Delphi diagnostic criteria.
3.1.2. Incidence of sFGR According to Diagnostic Criteria and Gestational Age at Diagnosis
The incidence of sFGR according to the different diagnostic criteria and gestational age at diagnosis
is shown in Table 2. According to the Delphi diagnostic criteria, 11.7% of the DC twin pregnancies were
classified as sFGR; 88 (8.4%) were early onset (<32 weeks), and 35 (3.3%) late-onset (≥32 weeks) sFGR.
Conversely, using the classification of early and late sFGR according to MC twins (before and after
24 weeks), 34 (3.2%) would be classified as early onset sFGR, and 89 (8.5%) late-onset sFGR. The criteria
with the least incidence of sFGR was EFW discordance of 25% plus umbilical artery PI of the smaller
twin >95th centile (n = 19, 1.8%). GA at diagnosis were similar in all criteria used, and regardless of
diagnostic criteria, early sFGR was more prevalent than late sFGR.
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Table 2. Incidence of selective fetal growth restriction (sFGR) in dichorionic twin pregnancies according to the various proposed diagnostic criteria as stated by a
consensus reached through a Delphi process (Khalil A 2019) and ISUOG twin guideline, as well the gestational age at diagnosis. Data are shown as number (%) or
median (IQR).






EFW < 3rd centile of one twin 95 (9.0) 80 (7.6) 27.0 (22.0–28.0) 15 (1.4) 34.0 (33.0–35.0)
Delphi criteria B
EFW < 10th centile of one twin +
inter-twin EFW discordance ≥ 25%
49 (4.7) 39 (3.7) 26.0 (22.0–28.0) 10 (1.0) 34.0 (32.0–35.0)
Delphi criteria C
EFW < 10th centile of one twin +
umbilical artery PI > 95th centile
60 (5.7) 36 (3.4) 28.0 (22.0–28.0) 24 (2.3) 33.5 (32.7–34.0)
Delphi criteria D
Inter-twin EFW discordance ≥ 25% +
umbilical artery PI > 95th centile
19 (1.8) 16 (1.5) 25.5 (22.0–28.0) 3 (0.3) 32.0 (32.0–32.0)
ISUOG criteria
EFW < 10th centile of one twin 162 (15.4) 116 (11.0) 27.0 (22.0–28.0) 46 (4.4) 34.0 (33.0–35.0)
ISUOG: The International Society of Ultrasound in Obstetrics and Gynecology; GA: gestational age; EFW: estimated fetal weight; PI: pulsatility index; n: number of patients.
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3.1.3. Disease Progression, Clinical Deterioration and Perinatal Outcomes
In those twin pregnancies diagnosed with sFGR according to the Delphi criteria, 44 (35.8%)
showed progression or clinical deterioration-39.8% of the early sFGR, compared to 25.7% of the late
sFGR. The interval between diagnosis and disease progression was 5 weeks in early sFGR, and one
week in the late sFGR group, with an average of 4 weeks in all the sFGR pregnancies (Table 3).
Table 3. Disease progression in dichorionic twin pregnancies complicated by selective fetal growth







Progression, n (%) 44 (35.8) 35 (39.8) 9 (25.7)
Interval between diagnosis and progression
in weeks, median (IQR) 4 (2–7) 5 (1–7.5) 1 (1–1)
Stable, n (%) 79 (64.2) 53 (60.2) 26 (74.3)
Stillbirth, neonatal and perinatal death were more common in the early sFGR group (11 per
1000 births, p < 0.001, 23 per 1000 births, p < 0.001, and 34 per 1000 births, p = 0.178 respectively).
We had no pregnancies complicated by IUD, NND or PND in the late sFGR group. There were no
significant differences in intrauterine demise (p = 0.664) or neonatal death (p = 0.464) between the sFGR
and non-sFGR groups; however, the perinatal death in the sFGR group was significantly higher than
the non-sFGR group (p = 0.018) (Table 4).
Pregnancies complicated by early sFGR were delivered earlier than late sFGR (34.0 vs. 35.0 weeks,
p < 0.083), and the birthweight was lower (2044g vs. 2128g, p = 0.011 in the larger twin, and 1529g vs.
1740g, p = 0.074 in the smaller twin); however, these results, with the exception of the birth weight of
the larger twin, were not statistically significant. NNU admissions were significantly higher in those
with early sFGR than late sFGR (p = 0.005).
We also performed an analysis of pregnancy outcomes for sFGR diagnosed according to the
ISUOG criteria (Table 5). The differences in outcomes compared to the no sFGR group, and the
comparisons between the early and late sFGR, were similar to those found diagnosed as sFGR by
the Delphi diagnostic criteria only. The outcomes compared with the Delphi diagnosed cases are
demonstrated in Figure 2. GA at delivery (35 vs. 34 weeks) and birthweight (1720 vs. 1660g in
smaller twin, and 2195 vs. 2107g in larger twin), although higher, were still significantly lower than
the non-sFGR group (p < 0.001 in both). The IUD (9 per 1000 births vs. 5 per 1000 birth) and PND
(22 per 1000 births vs. 16 per 1000 birth) were not significantly different in the sFGR versus non-sFGR
groups (p > 0.05). Both outcomes were more common in the early sFGR (13 per 1000 births and
30 per 1000 births, respectively). Of the pregnancies classified as sFGR according to ISUOG criteria,
but did not meet the Delphi criteria (n = 39), only one pregnancy suffered an IUD, with no cases of
NND. This occurred in the larger twin at 28 weeks, and no obvious cause was found for the demise.
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Table 4. Perinatal outcomes in dichorionic twin pregnancies according to whether they were complicated by sFGR or not according to the Delphi diagnostic criteria








(n = 35) p-Value
Gestation at birth (weeks) 34.0 (33.0–36.0) 37.0 (35.0–37.0) <0.001 34.0 (31.8–36.0) 35.0 (33.5–36.0) 0.083
Birth weight (g), larger baby 2107 (1771–2339) 2640 (2345–2920) <0.001 2044 (1656–2328) 2128 (1985–2377) 0.011
Birth weight (g), smaller baby 1660 (1192–1846) 2362 (2080–2601) <0.001 1529 (1130–1815) 1740 (1588–1895) 0.074
Birth weight centile, larger baby 36.0 (18.7–55.1) 63.5 (43.4–82.1) <0.001 39.3 (11.6–80.5) 20.7 (1.2–72.3) 0.062
Birth weight centile, smaller baby 3.2 (1.1–7.8) 34.3 (14.4–52.7) <0.001 5.6 (0.5–12.9) 4.6 (0.3–13.6) 0.295
Intrauterine demise
(per 1000 total birth †) 2 (8) 10 (5) 0.644 ‡ 2 (11) 0 (0) <0.001 ‡
Neonatal death
(per 1000 live birth †) 4 (16) 19 (10) 0.464 ‡ 4 (23) 0 (0) <0.001 ‡
Perinatal death
(per 1000 total birth †) 6 (24) 29 (16) 0.018 ‡ 6 (34) 0 (0) 0.178 ‡
Survival of at least one twin 122 (99.2) 925 (99.5) 0.703 87 (98.9) 35 (100.0) 0.999
Survival of both twins 118 (95.9) 896 (96.3) 0.821 83 (94.3) 35 (100.0) 0.350
Neonatal unit admission * 133 (54.5) 389 (21.2) <0.001 ‡ 105 (60.3) 28 (40.0) 0.005 ‡
* Denominator excludes fetuses complicated by intrauterine death or missing neonatal admission outcome † Rounded to nearest whole number ‡ Generalized estimating equation
model results.
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Table 5. Perinatal outcomes in dichorionic twin pregnancies according to whether they were complicated by sFGR or not according to the ISUOG diagnostic criteria in








(n = 46) p-Value
Gestation at birth (wks) 35.0 (33.0–37.0) 37.0 (35.0–37.0) <0.001 35.0 (32.0–37.0) 35.0 (34.0–36.7) 0.131
Birth weight (g), larger baby 2195 (1856–3450) 2660 (2350–2950) <0.001 2164 (1738–2447) 2222 (2024–2530) 0.062
Birth weight (g), smaller baby 1720 (1400–1920) 2390 (2105–2615) <0.001 1680 (1173–1910) 1747 (1645–1958) 0.062
Birth weight centile, larger baby 36.2 (21.0–54.3) 64.4 (44.8–82.6) <0.001 34.6 (22.2–51.7) 38.0 (18.9–58.4) 0.568
Birth weight centile, smaller baby 3.9 (1.5–8.0) 35.8 (18.9–55.3) <0.001 3.5 (1.1–7.3) 4.8 (1.8–9.2) 0.194
Intrauterine demise
(per 1000 total birth †) 3 (9) 9 (5) 0.370 ‡ 3 (13) 0 (0) <0.001 ‡
Neonatal death
(per 1000 live birth †) 4 (12) 19 (11) 0.758 ‡ 4 (17) 0 (0) <0.001 ‡
Perinatal death
(per 1000 total birth †) 7 (22) 28 (16) 0.069 ‡ 7 (30) 0 (0) 0.150 ‡
Survival of at least one twin 161 (99.4) 888 (99.7) 0.593 115 (99.1) 46 (100.0) 0.999
Survival of both twins 156 (96.3) 866 (97.2) 0.534 110 (94.8) 46 (100.0) 0.266
Neonatal unit admission * 155 (48.4) 367 (20.8) <0.001 ‡ 121 (53.1) 34 (37.0) 0.009 ‡
* Denominator excludes fetuses complicated by intrauterine death or missing neonatal admission outcome † Rounded to nearest whole number ‡ Generalized estimating equation
model results.
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Figure 2. Perinatal and neonatal outcomes of sFGR DCDA twins according to Delphi and
ISUOG diagnostic criteria: (a) Bar chart demonstrating the incidence of IUD (intrauterine demise),
NND (neonatal death), and PND (perinatal death) in the Delphi and ISUOG criteria groups; (b) Bar
chart demonstrating the incidence of neonatal outcomes (survival of one twin, survival of both twins,
and neonatal unit (NNU) admissions) according to Delphi and ISUOG criteria groups.
4. Discussion
4.1. Summary of the Study Findings
According to ISUOG diagnostic criteria (EFW of one twin < 10th centile), the incidence of sFGR
in this population of unselected dichorionic twin pregnancies was 15.4%. The incidence varied
according to the diagnostic criteria used, with lower incidence when using the recently published
Delphi diagnostic criteria (11.7%). In pregnancies diagnosed with sFGR, the GA at delivery was
significantly earlier, and the NNU admission higher, than those without sFGR. The overall prevalence
of early sFGR (72%) was significantly higher than late sFGR (28%). The rate of neonatal unit admission
was significantly higher in the early sFGR group. These pregnancies also showed a higher progression
rate than the late sFGR group, but a longer interval between diagnosis to disease progression.
4.2. Clinical and Research Implications
The ISUOG diagnostic criteria classified the highest number of twins as sFGR, and the lowest
number was classified according to the Delphi criteria of inter-twin discordance >25% and UA PI >95th
centile. The latter category may therefore reflect the most severe form of sFGR, whereas the former
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criteria may diagnose healthy small twins as sFGR. The one case of IUD in the cohort classified as
sFGR according to the ISUOG but not the Delphi criteria was unlikely related to sFGR, as it occurred
in the larger twin, and demonstrates the likelihood that this group of pregnancies may in fact be
healthy small twins. Twins are known to have lower than average birth weights, as well as slowed
growth in the third trimester [17]. Despite this, singleton growth charts are still routinely used in
twin pregnancies, leading to an over-diagnosis of small for gestational age (SGA), with no increased
risk of perinatal death in DC twins compared to singletons [18]. We published twin specific growth
ranges through the analysis of a large cohort of twin pregnancies, which is now routinely used in
our unit, and also for the calculations in our study [13,19,20]. In the latter study by Stirrup et al.,
we found that DC twins followed a similar growth trajectory to singletons until 30 weeks, followed by
a relative reduction in growth velocity thereafter [13]. Therefore, by solely using centile-based criteria
(e.g., EFW < 10th centile) to diagnose sFGR, significant variation in sFGR prevalence can be introduced
depending on the growth chart used. The inevitable consequences of the latter are over-diagnosis of
sFGR and unnecessary iatrogenic early delivery of appropriate for gestational age (AGA) twins.
Management of sFGR in twin pregnancies poses a clinical conundrum. It is recognised that
growth discordance, particularly when one is growth restricted, can carry an increased risk of perinatal
death [21]. Expectant management can result in single fetal demise in the growth restricted twin,
which can in turn lead to preterm delivery in 54%, and carries a 2% risk of neurological damage, and 3%
risk of co-twin demise in the live twin [22]. Elective premature birth, however, carries significant risks
of prematurity in the AGA twin. Selective fetal reduction has a limited role in DC twins, due to the
risk of preterm birth, but has been reported to be used in cases of severe preterm pre-eclampsia [23].
Our results illustrate the importance of using standard diagnostic criteria of sFGR and could
explain the large variation among the published studies. Recent international efforts have also
focused on standardizing the outcomes reported in twin studies [24,25]. One future research priority,
which has been identified by the global twins and multiples priority setting partnership, is how we
can assess the growth of twin infants after birth and how to ensure that they follow a satisfactory
growth trajectory [26]. Despite the fact that the EFW reference ranges are representative of the whole
population, the traditional approach of deriving birth weight charts has been criticised, as a large
proportion of babies born preterm could result from pathological pregnancies. This is a significant
concern in twin pregnancies in view of the high rate of preterm birth.
4.3. Interpretation of Study Findings and Comparison with Existing Literature
As the existing literature on sFGR in DC twin pregnancies is scarce, and they are managed in a
similar fashion to singleton pregnancies, we have adopted an approach to extrapolate from singletons
with FGR. Vanlieferinghen et al. found that the time from the first abnormal umbilical artery Doppler
finding to the time of delivery was significantly longer in growth restricted DC twins than in singletons
(53 vs. 16 days), and that twins with sFGR were delivered later than singletons, with no difference in
outcome [9]. This could be due to clinician bias, in order to delay delivery for the sake of the AGA twin,
or could reflect a slower disease progression in twins compared to singletons. Comparing our findings
to their singleton data, a mean interval from diagnosis to delivery was 21 days in their singleton group,
and in our cohort, the mean interval from diagnosis to disease progression (i.e., Doppler deterioration)
was four weeks (28 days). Our mean birthweight was 1801g in the sFGR group, and their singletons
had a median birthweight of 1380g. The gestation at delivery in our sFGR group was comparable to
their singleton group (33.99 vs. 33.6 weeks). The TRUFFLE (Trial of Randomized Umbilical and Fetal
FLow in Europe) study analysed perinatal outcomes in a cohort of severe early onset growth restricted
singleton pregnancies. The average gestation at delivery was 30 + 5 weeks, with a diagnosis to
delivery time of 8 days, and a mean birth weight of 1013g [27]. However, their diagnostic criteria used
abdominal circumference <10th centile, and UA PI >95th centile, which differs from our study criteria.
The lower progression rate and better outcomes in the late sFGR group in this study may be
explained, by the fact that they were electively delivered shortly following diagnosis, due to their later
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gestations. The lack of significant difference in the intrauterine or neonatal deaths in the DC twin
pregnancies complicated by sFGR could also be explained by intervention bias. As these pregnancies
were monitored closely and delivered early, therefore, reducing the risk of intrauterine demise of the
smaller twin. However, when combined, the rate of perinatal mortality was significantly higher in the
sFGR group, which may be more highly contributed by the number of neonatal deaths, secondary to
the lower gestation at delivery and lower birthweights. In light of these findings, it may be reasonable
to suggest that management can be more conservative in DC twin pregnancies, and unnecessary
preterm delivery may be reduced with continued close ultrasound observation.
We have recently published a study describing the natural history of sFGR in monochorionic twin
pregnancies according to the recent diagnostic criteria [28]. The incidence of early sFGR was 4.9%,
while that of late sFGR was 3.8%, according to ISUOG diagnostic criteria. When applying the various
diagnostic criteria, the incidence of early sFGR varied from 1.7% to 9.1% and late sFGR from 1.1% to
5.9%. It is important though to point out that we used a different cut-off (<24 weeks’ gestation) to
define early vs. late-onset sFGR taking into account viability and gestational age threshold of active
fetal intervention in these pregnancies.
4.4. Strengths and Limitations
Our study reports the prevalence of early and late sFGR in DC twins according to different
diagnostic criteria, the natural history of the disease, and perinatal outcomes, in a large cohort of
twin pregnancies. The main limitation is its retrospective nature, and that we did not adjust for the
background patient demographics. However, it is unlikely to impact the study outcomes. The link
of a priori risk factors and sFGR in DC twin pregnancies is not well established and the published
literature reports controversial findings [29–33]. The lack of significant differences in still birth and
neonatal deaths in sFGR and non-sFGR, as well as between the early and late sFGR groups should be
interpreted with caution as the number of pregnancies in these analyses might be too small. For future
research, it would be beneficial to compare these outcomes and disease progression with singleton
pregnancies using the same diagnostic criteria, in order to ascertain whether there is a true difference
in the natural history of the disease. As the clinicians were not blinded to the ultrasound findings,
the potential risk of intervention bias is very likely.
Due to the number of patients who were lost to follow-up, and the patients who delivered
prior to the availability of an electronic neonatal database, we were unable to adequately retrieve
neonatal morbidity data to allow for reliable analysis, which would have provided additional valuable
information in the comparison of the diagnostic criteria. Furthermore, the retrospective study design
poses a risk of selection and classification bias, and this together with patients who were lost to
follow-up can make accurate comparisons difficult to make. Therefore, these outcomes should also be
interpreted with caution. Future prospective studies using population-based registries, which extends
to long-term follow-up for these twins will be beneficial in providing a more precise assessment of
development and growth trajectories, as well as developmental information.
5. Conclusions
The incidence of sFGR in DC twin pregnancies varies according to the diagnostic criteria used.
The ISUOG diagnostic criteria, compared to the Delphi diagnostic criteria, may lead to early iatrogenic
delivery and unnecessary parental anxiety. Early sFGR is significantly more prevalent than late sFGR,
and has a worse perinatal outcome. The overall progression of disease is seen in a third of these
pregnancies, with a longer time of progression than reported in singleton pregnancies. The use of twin
specific growth charts and the Delphi diagnostic criteria may reduce the diagnosis of sFGR, without a
significant effect on perinatal mortality, and possibly reducing perinatal morbidities through avoiding
unnecessary preterm deliveries. Further prospective studies extending to long-term follow-up of these
twins will help to provide more accurate comparisons and developmental assessments.
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